The Ocular Surface in a Broader Perspective
In persistent tear film dysfunction and ocular discomfort, response to standard lubricants may sometimes prove incomplete. Current clinical literature suggests that chronic blepharitis, meibomian changes, and epithelial fragility may occasionally correlate with subclinical systemic inflammation, metabolic factors, or mucosal axis imbalances. A structured ophthalmic evaluation pairs guideline-directed ocular therapy with a considered overview of the patient's biological terrain.
Blepharitis & Meibomian Dysfunction
Lid margin inflammation and recurrent chalazia frequently reflect qualitative meibum alterations, which may warrant assessment alongside broader metabolic and nutritional contexts.
Blepharitis Overview →Dry Eye & Immune Pathways
In marked aqueous deficiency or autoimmune-associated conditions (such as Sjögren's syndrome), dedicated specialist follow-up remains central to preserving corneal epithelial stability.
Dry Eye Overview →Ocular Rosacea & Hyper-reactivity
Conjunctival hyperemia, telangiectasia, and mucosal sensitivity necessitate measured inflammatory control to limit chronic epithelial stress and sustain surface integrity.
Rosacea & Allergies →Advanced Surface Therapies
In refractory presentations non-responsive to first-line regimens, specialized care may explore biological or compounded modalities: topical cyclosporine for inflammatory modulation, autologous serum for natural trophic factors, compounded insulin to assist epithelial healing, and topical losartan directed at managing corneal stromal haze.
Explore Advanced Therapies →